
Rhizome AI YC Application
Rhizome AI went through Y Combinator in the Winter 2026 batch as a B2B company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Winter 2026
- Industry
- B2B
- Team size
- 1
- Status
- Active
- Launched
- 2026
Founders
Chetan MishraFounder
What Rhizome AI does
It takes 500,000 days of office work to bring a drug to market. We want to make it 5. To get there, we need agents doing most of the work. Today, our research agent is the best way to know what the FDA thinks. Users ask a question and get an answer backed by up to 1,000 documents, where each statement has a citation. It’s the best because we have the best retrieval engine. We’ve tuned it on our life science-specific dataset, and we find what others miss. As more teams use Rhizome, we gain more data on what regulatory professionals actually need, which makes retrieval even better. This flywheel is how we become the retrieval engine that powers all human and agent work in life sciences. Chetan started his career as a research engineer, but quickly realized he enjoyed building more than research. He joined EvolutionaryScale as their sole founding product engineer, launching their developer-scientist platform and scaling to tens of thousands of users and billions of API calls. He was also #16 at Instabase helping banks with document processing, closing $7m as the technical closer. Agents can do magical things today, but most in life sciences only use them to edit emails. Agents are missing the context they need to 100x the number of drugs we can bring to market. Rhizome AI is focused on that critical problem.
Rhizome AI's YC application, reconstructed
Y Combinator application
Rhizome AI, Winter 2026 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Rhizome AI
Agent Platform for Life Sciences
We built a research agent that helps regulatory professionals understand FDA guidance by answering their questions with citations from up to 1,000 relevant documents. It's powered by a retrieval engine tuned specifically on life science datasets that finds regulatory information others miss. Our product aims to automate much of the work involved in navigating drug approval processes.
I live in New York City and the company is based there and remotely distributed.
New York is a major life sciences hub, and remote lets us access talent and customers globally. This fits our need to stay close to regulatory experts and life sciences teams while keeping flexibility.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real Rhizome AI YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Rhizome AI's public data (launch notes, founder backgrounds, product description). It shows how a company like Rhizome AI would present itself to YC, not the text they submitted.
What YC batch was Rhizome AI in?
Rhizome AI was part of the Y Combinator Winter 2026 batch.
Who founded Rhizome AI?
Rhizome AI was founded by Chetan Mishra.
What does Rhizome AI do?
Agent Platform for Life Sciences
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of Rhizome AI's application, and every other YC batch, is in YC Insights.